600 patients66,869 observations120 daysLIVE
← Patients

Patient P-01392

Synthetic patientNBL-101 · Day 120 · 35–44 · F · baseline S03Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Improving
GI state
Favorable
Inflammatory state
Improving
Nutritional resilience
Favorable
Discontinuation risk
13%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 started — Baseline state S03
  2. Day 12 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 12.

Primary contributors, last 14 days
  • Toxicity-26
  • Inflammatory activity-16
  • Nutritional resilience+4
  • Treatment adherence+4

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    GI burden
    Companion
    26.3/100
    improving · -4.6 vs previous 14 d
    Toxicity
    Blood
    3.3/100
    improving · -13.2 vs previous 14 d
    Sleep quality
    Wearable
    63.4/100
    improving · +7.2 vs previous 14 d
    Energy level
    Daily log
    6.4/10
    improving · +0.8 vs previous 14 d
    Stress level
    Daily log
    4.3/10
    improving · -0.7 vs previous 14 d
    Steps
    Wearable
    6,024
    improving · +580 vs previous 14 d
    Adherence
    Companion
    91.6 %
    stable · -0.7 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 66 from the failing basin, 32 from restoration.

    Good elements to keep
    • Stable without identifiable pulls.
    Main detractors to watch
    • Low butyrate capacity
      hidden · steering -17.5
    • Poor metabolizer
      hidden · steering -12.7
    • Low microbial diversity
      hidden · steering -7.7
    • Enterobacteriaceae elevated
      hidden · steering -7.4
    • Simple carbohydrates
      detractor · GI +4.2 next day
    • Dietary fat load
      detractor · GI +3.9 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Simple carbohydrates
      +4.2detractor · 95%
    • Dietary fat load
      +3.9detractor · 95%
    • Histamine load
      +1.3no signal · 35%
    • Insoluble fibre
      +1.2no signal · 27%
    • Alcohol
      +1.1no signal · 25%
    • Spicy / capsaicin
      -1no signal · 22%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Drug metabolism and exposure ↑75
      • DNACYP2D6 poor metabolizer → higher exposure
      • DNADPYD *2A → slower clearance
    • Butyrate / short-chain fatty acid production ↓60
      • MicrobiomeButyrate capacity 35/100
      • MicrobiomeF. prausnitzii depleted
    • Mucosal barrier integrity ↓30
      • MicrobiomeAkkermansia low → thinner mucus layer
    DNA
    Fictional pharmacogenomic panel
    • DPYD *2A heterozygous
      Slower drug clearance
    • CYP2D6 Poor metabolizer
      Higher exposure at standard dose
    • MTHFR C677T
      Reduced folate turnover
    Microbiome
    Shannon diversity 2.7 · butyrate capacity 35/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisNormal
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    58 ms
    Sleep
    7.6 h
    Steps
    5,054
    Resting HR
    56 bpm
    Daily log: GI score 26, nutritional resilience 60, adherence 92.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0154141%S09AD-05no change43
    P-0137740%S11AD-05no change42
    P-0148339%S14AD-05no change35
    P-0167933%S12AD-05no change39
    P-0180431%S19AD-05improved61
    P-0177329%S05AD-05improved27
    P-0184828%S05AD-05no change23
    P-0131338%S01BR-03improved32
    P-0146835%S06BR-03no change41
    P-0135034%S19BR-03no change34
    P-0145034%S09BR-03no change36
    P-0168934%S13BR-03no change50